235 related articles for article (PubMed ID: 9240541)
1. Comparison of the relative incidence of impalpable invasive breast carcinoma and ductal carcinoma in situ in cancers detected in patients older and younger than 50 years of age.
Evans WP; Starr AL; Bennos ES
Radiology; 1997 Aug; 204(2):489-91. PubMed ID: 9240541
[TBL] [Abstract][Full Text] [Related]
2. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
Ringberg A; Andersson I; Aspegren K; Linell F
Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
[TBL] [Abstract][Full Text] [Related]
3. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
[TBL] [Abstract][Full Text] [Related]
4. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
5. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
6. Reduction mammaplasty specimens and occult breast carcinomas.
Kakagia D; Fragia K; Grekou A; Tsoutsos D
Eur J Surg Oncol; 2005 Feb; 31(1):19-21. PubMed ID: 15642421
[TBL] [Abstract][Full Text] [Related]
7. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological survey of preinvasive breast cancer.
Vandenbroucke A; Bourdon C
Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():3-10. PubMed ID: 8298449
[TBL] [Abstract][Full Text] [Related]
9. Lobular carcinoma in situ on core biopsy-what is the clinical significance?
O'Driscoll D; Britton P; Bobrow L; Wishart GC; Sinnatamby R; Warren R
Clin Radiol; 2001 Mar; 56(3):216-20. PubMed ID: 11247699
[TBL] [Abstract][Full Text] [Related]
10. Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up.
Mahoney MC; Robinson-Smith TM; Shaughnessy EA
AJR Am J Roentgenol; 2006 Oct; 187(4):949-54. PubMed ID: 16985141
[TBL] [Abstract][Full Text] [Related]
11. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
Ji J; Hemminki K
Breast Cancer Res Treat; 2007 Oct; 105(2):229-36. PubMed ID: 17115107
[TBL] [Abstract][Full Text] [Related]
12. Incidental atypical proliferative lesions in reduction mammoplasty specimens: analysis of 2498 cases from 2 tertiary women's health centers.
Desouki MM; Li Z; Hameed O; Fadare O; Zhao C
Hum Pathol; 2013 Sep; 44(9):1877-81. PubMed ID: 23656973
[TBL] [Abstract][Full Text] [Related]
13. Trends in breast cancer at a county hospital.
Hoehne FM; Taylor E
Am Surg; 2005 Feb; 71(2):159-63. PubMed ID: 16022017
[TBL] [Abstract][Full Text] [Related]
14. Screening breast MR imaging in women with a history of lobular carcinoma in situ.
Sung JS; Malak SF; Bajaj P; Alis R; Dershaw DD; Morris EA
Radiology; 2011 Nov; 261(2):414-20. PubMed ID: 21900617
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous large-core biopsy of papillary breast lesions.
Liberman L; Bracero N; Vuolo MA; Dershaw DD; Morris EA; Abramson AF; Rosen PP
AJR Am J Roentgenol; 1999 Feb; 172(2):331-7. PubMed ID: 9930777
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic breast biopsy of atypical ductal hyperplasia and ductal carcinoma in situ lesions: improved accuracy with directional, vacuum-assisted biopsy.
Burbank F
Radiology; 1997 Mar; 202(3):843-7. PubMed ID: 9051043
[TBL] [Abstract][Full Text] [Related]
17. MR imaging of ductal carcinoma in situ.
Orel SG; Mendonca MH; Reynolds C; Schnall MD; Solin LJ; Sullivan DC
Radiology; 1997 Feb; 202(2):413-20. PubMed ID: 9015067
[TBL] [Abstract][Full Text] [Related]
18. Changing incidence rate of invasive lobular breast carcinoma among older women.
Li CI; Anderson BO; Porter P; Holt SK; Daling JR; Moe RE
Cancer; 2000 Jun; 88(11):2561-9. PubMed ID: 10861434
[TBL] [Abstract][Full Text] [Related]
19. Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
Collins LC; Tamimi RM; Baer HJ; Connolly JL; Colditz GA; Schnitt SJ
Cancer; 2005 May; 103(9):1778-84. PubMed ID: 15770688
[TBL] [Abstract][Full Text] [Related]
20. Five-year survival of 100 women with carcinoma of the breast diagnosed by screening mammography and needle-localization biopsy.
Bauer TL; Pandelidis SM; Rhoads JE
J Am Coll Surg; 1994 May; 178(5):427-30. PubMed ID: 8167877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
